AJP - Cell Physiology, Vol 270, Issue 3 C778-C785, Copyright © 1996 by American Physiological Society

ARTICLES

Role of nitric oxide and phosphodiesterase isoenzyme II for reduction of endothelial hyperpermeability

N. Suttorp, S. Hippenstiel, M. Fuhrmann, M. Krull and T. Podzuweit
Department of Internal Medicine, Justus Liebig-University of Giessen, Germany.

Regulation of endothelial permeability is poorly understood. Previous studies have shown that endothelial cells contain phosphodiesterase (PDE) isoenzymes II-IV and that simultaneous adenylate cyclase activation and/or PDE inhibition blocked endothelial hyperpermeability (J.Clin.Invest. 91: 1421-1428, 1993). We now focused on a possible role for guanosine 3',5'-cyclic monophosphate (cGMP)-dependent mechanisms and studied H2O2-exposed porcine pulmonary artery endothelial cell monolayers. Pretreatment of cells with different nitric oxide (NO) donors or atrial natriuretic peptide (ANP) increased endothelial cGMP-content severalfold and blocked H2O2-related effects on permeability; opposite results were obtained with a NO synthase inhibitor. Determination of cGMP degradation in nitroprusside-exposed endothelial cells identified PDE II as the major cGMP metabolizing pathway, whereas PDE III and IV contributed little or nothing. Inhibition of PDE II reduced H2O2-related endothelial hyperpermeability, an effect that could be enhanced synergistically by simultaneous guanylate cyclase activation. In summary, these studies indicate that cGMP-dependent mechanisms (NO donors, ANP, and dibutyryl-cGMP) blocked H2O2-related increases in endothelial permeability. The major cGMP degrading pathway in endothelial cells was PDE II, thereby substituting the missing PDE V in these cells. Simultaneous guanylate cyclase activation and/or PDE II inhibition may be a valuable approach to treat endothelial hyperpermeability.

This article has been cited by other articles:

				O. Rentsendorj, T. Mirzapoiazova, D. Adyshev, L. E. Servinsky, T. Renne, A. D. Verin, and D. B. Pearse Role of vasodilator-stimulated phosphoprotein in cGMP-mediated protection of human pulmonary artery endothelial barrier function Am J Physiol Lung Cell Mol Physiol, April 1, 2008; 294(4): L686 - L697. [Abstract] [Full Text] [PDF]

				A. Moldobaeva, L. E. Welsh-Servinsky, L. A. Shimoda, R. S. Stephens, A. D. Verin, R. M. Tuder, and D. B. Pearse Role of protein kinase G in barrier-protective effects of cGMP in human pulmonary artery endothelial cells Am J Physiol Lung Cell Mol Physiol, May 1, 2006; 290(5): L919 - L930. [Abstract] [Full Text] [PDF]

				S. B. Tarpey, D. R. Sawmiller, C. Kelly, W. J. Thompson, and M. I. Townsley Phosphodiesterase 3 activity is reduced in dog lung following pacing-induced heart failure Am J Physiol Lung Cell Mol Physiol, May 1, 2003; 284(5): L766 - L773. [Abstract] [Full Text] [PDF]

				F. Rose, B. Guthmann, T. Tenenbaum, L. Fink, A. Ghofrani, N. Weissmann, P. Konig, L. Ermert, G. Dahlem, J. Haenze, et al. Apical, But Not Basolateral, Endotoxin Preincubation Protects Alveolar Epithelial Cells Against Hydrogen Peroxide-Induced Loss of Barrier Function: The Role of Nitric Oxide Synthesis J. Immunol., August 1, 2002; 169(3): 1474 - 1481. [Abstract] [Full Text] [PDF]

				G. K. RANGAN, Y. WANG, and D. C. H. HARRIS Pharmacologic Modulators of Nitric Oxide Exacerbate Tubulointerstitial Inflammation in Proteinuric Rats J. Am. Soc. Nephrol., August 1, 2001; 12(8): 1696 - 1705. [Abstract] [Full Text] [PDF]

				K. Sadhu, K. Hensley, V. A. Florio, and S. L. Wolda Differential Expression of the Cyclic GMP-stimulated Phosphodiesterase PDE2A in Human Venous and Capillary Endothelial Cells J. Histochem. Cytochem., July 1, 1999; 47(7): 895 - 906. [Abstract] [Full Text]

				C. C. Michel and F. E. Curry Microvascular Permeability Physiol Rev, July 1, 1999; 79(3): 703 - 761. [Abstract] [Full Text] [PDF]

				V. W.M. van Hinsbergh Endothelial Permeability for Macromolecules: Mechanistic Aspects of Pathophysiological Modulation Arterioscler. Thromb. Vasc. Biol., June 1, 1997; 17(6): 1018 - 1023. [Full Text]